By using DiabetesTimes.co.uk, you agree to our terms and use of cookies to enhance your experience.

Conference delegates invited to QiC symposium

By Editor
2nd March 2017
Case studies

Delegates who are attending next week’s Diabetes UK Professional Conference are being invited to join the Quality in Care Diabetes symposium at the event.

The one-hour symposium, which will showcase QiC’s innovation in practice, will be chaired by Dr Parijat De from Sandwell and West Birmingham NHS Trust.

A number of projects which were recognised at the 2016 QiC Diabetes awards will also be covered, including HeLP-Diabetes, which is an online solution for diabetes self-management support.

Dr Mihirani Balapatabendi, a consultant paediatrician from Gloucestershire Hospitals NHS Foundation Trust, will present on dedicated annual review clinics for children with type 1 diabetes.

Investing in Children CIC’s project worker Chloe Brown will also talk about expanding the Type 1 Kidz Project and its introduction of simple telehealth services.

Proceedings will then be wrapped up with a Q&A session moderated by consultant physician Dr De, himself recognised at QiC Diabetes 2016 as Diabetes Healthcare Professional of the Year.

Click here to download the program.

To register your interest in attending the QiC Diabetes symposium Thursday, March 9, 13:20-14:20, Charter 3, email sthwaites@qualityincare.org

This symposium is only available to delegates registered for the Diabetes UK Professional Conference 2017.

QiC Diabetes is partnered by Sanofi and supported by the Association of British Clinical Diabetologists (ABCD)Children and Young People’s Diabetes Network (CYPDN), the Diabetes Inpatient Specialist Nurse (DISN) UK GroupDiabetes Research & Wellness Foundation (DRWF)Diabetes UKPrimary Care Diabetes Society (PCDS)Training Research and Education for Nurses in Diabetes (TREND)Young Diabetologists and Endocrinologists’ Forum (YDEF) and the United Kingdom Clinical Pharmacy Association (UKCPA).

QiC Diabetes has been made possible with sponsorship from Sanofi. Sanofi has had no editorial control over any of its contents.

Comments (0)

Register an account or login to comment